Literature DB >> 2683162

Leukocyte-endothelial cell interaction and the control of leukocyte migration into inflamed synovium.

S Jalkanen1.   

Abstract

Mesh:

Substances:

Year:  1989        PMID: 2683162     DOI: 10.1007/bf00197188

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN: 0344-4325


× No keyword cloud information.
  47 in total

1.  The role of the lymphocyte and its products in the propagation of joint disease.

Authors:  C M Pearson; H E Paulus; H I Machleder
Journal:  Ann N Y Acad Sci       Date:  1975-06-13       Impact factor: 5.691

2.  Anti-Ia monoclonal antibody (10-2.16) inhibits lymphocyte-high endothelial venule (HEV) interaction.

Authors:  N Manolios; C Geczy; L Schrieber
Journal:  Cell Immunol       Date:  1988-11       Impact factor: 4.868

3.  Binding of normal human mononuclear cells to blood vessels in rheumatoid arthritis synovial membrane.

Authors:  N Oppenheimer-Marks; M Ziff
Journal:  Arthritis Rheum       Date:  1986-06

4.  Changes in vascular endothelium related to lymphocyte collections in diseased synovia.

Authors:  A J Freemont; C J Jones; M Bromley; P Andrews
Journal:  Arthritis Rheum       Date:  1983-12

5.  Evidence for an accessory role of LFA-1 in lymphocyte-high endothelium interaction during homing.

Authors:  A Hamann; D Jablonski-Westrich; A Duijvestijn; E C Butcher; H Baisch; R Harder; H G Thiele
Journal:  J Immunol       Date:  1988-02-01       Impact factor: 5.422

6.  Evidence that leukocyte function-associated antigen-1 is involved in recirculation and homing of human lymphocytes via high endothelial venules.

Authors:  S T Pals; A den Otter; F Miedema; P Kabel; G D Keizer; R J Scheper; C J Meijer
Journal:  J Immunol       Date:  1988-03-15       Impact factor: 5.422

7.  Immunohistologic characterization of synovial membrane lymphocytes in rheumatoid arthritis.

Authors:  C L Young; T C Adamson; J H Vaughan; R I Fox
Journal:  Arthritis Rheum       Date:  1984-01

8.  An endothelial cell surface factor(s) induced in vitro by lipopolysaccharide, interleukin 1, and tumor necrosis factor-alpha increases neutrophil adherence by a CDw18-dependent mechanism.

Authors:  T H Pohlman; K A Stanness; P G Beatty; H D Ochs; J M Harlan
Journal:  J Immunol       Date:  1986-06-15       Impact factor: 5.422

9.  Preferential expression of fibronectin receptors on immature thymocytes.

Authors:  P M Cardarelli; I N Crispe; M D Pierschbacher
Journal:  J Cell Biol       Date:  1988-06       Impact factor: 10.539

10.  THE ORIGIN OF THE CELLS IN THE EFFERENT LYMPH FROM A SINGLE LYMPH NODE.

Authors:  J G HALL; B MORRIS
Journal:  J Exp Med       Date:  1965-06-01       Impact factor: 14.307

View more
  5 in total

Review 1.  Vascular endothelium, cytokines, and the pathogenesis of inflammatory synovitis.

Authors:  A Kaul; D R Blake; J D Pearson
Journal:  Ann Rheum Dis       Date:  1991-11       Impact factor: 19.103

2.  Differential expression of the urokinase receptor (CD87) in arthritic and normal synovial tissues.

Authors:  Z Szekanecz; G K Haines; A E Koch
Journal:  J Clin Pathol       Date:  1997-04       Impact factor: 3.411

3.  4A11, a monoclonal antibody recognizing a novel antigen expressed on aberrant vascular endothelium. Upregulation in an in vivo model of contact dermatitis.

Authors:  A E Koch; B J Nickoloff; J Holgersson; B Seed; G K Haines; J C Burrows; S J Leibovich
Journal:  Am J Pathol       Date:  1994-02       Impact factor: 4.307

4.  Tryptase is a candidate autoantigen in rheumatoid arthritis.

Authors:  Yanyan Guo; Qiao Wu; Bing Ni; Zhirong Mou; Qiong Jiang; Yi Cao; Hui Dong; Yuzhang Wu
Journal:  Immunology       Date:  2014-05       Impact factor: 7.397

5.  Increased binding of synovial T lymphocytes from rheumatoid arthritis to endothelial-leukocyte adhesion molecule-1 (ELAM-1) and vascular cell adhesion molecule-1 (VCAM-1).

Authors:  A A Postigo; R Garcia-Vicuña; F Diaz-Gonzalez; A G Arroyo; M O De Landázuri; G Chi-Rosso; R R Lobb; A Laffon; F Sánchez-Madrid
Journal:  J Clin Invest       Date:  1992-05       Impact factor: 14.808

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.